Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 78 clinical trials
Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke (ATAMIS)

The risk of early recurrence or progression of acute ischemic stroke is very high, even in patients treated with aspirin. The Chance study show that clopidogrel plus aspirin treatment reduced

transient ischemic attack
clopidogrel
deficit
stroke
aspirin
  • 4 views
  • 12 Mar, 2022
  • 1 location
Study on Tirofiban With Aspirin in the Treatment of Acute Penetrating Artery Territory Infarction (STRATEGY)

(clopidogrel plus aspirin) did not significantly reduce the risk of recurrent stroke. The primary purpose of this study is to assess the efficacy and safety of tirofiban combined with aspirin versus placebo

  • 0 views
  • 14 May, 2022
  • 20 locations
Balloon Angioplasty for Symptomatic Intracranial Artery Stenosis (BASIS)

Intracranial atherosclerotic disease (ICAD) is the most common cause of ischemical cerebrovascular events. The risk of stroke recurrence or death of ICAD patients remains very high. Even with aggressive medical management including dual antiplatelet therapy and strict management of risk factors, 12.2 percent of patients with 70-99 percent stenosis of …

  • 0 views
  • 24 Apr, 2022
  • 28 locations
Efficacy of Clopidogrel on Incidence of Silent Brain Infarction (ECISBI)

controls. Higher coated-platelet levels are strongly associated with both the presence and number of SBIs. Among medications approved for preventing stroke recurrence, we identified clopidogrel as a

  • 0 views
  • 22 Apr, 2022
  • 1 location
Clopidogrel Monotherapy in Patients With High Bleeding Risk

The goal of this research is to show that a shorter duration of two antiplatelet medications (compared to the standard of care) is safe and effective while reducing the risk of bleeding complications. Bleeding complications can cause significant problems (hospitalizations, need for blood transfusions, and even death) for patients on …

  • 0 views
  • 27 Apr, 2022
  • 1 location
External Counterpulsation Therapy for Severe Steno-occlusive Intracranial Stenosis

Intracranial stenosis is prevalent among Asians and constitute a common cause of cerebral ischemia. While the best medical therapy carries stroke recurrence rates in access of 10% per year, intracranial stenting was associated with unacceptable peri-procedural ischemic events. Cerebral ischemic events are strongly related to the severity of intracranial stenosis, …

stroke
cerebral infarction
ischemia
acute stroke
stenosis
  • 23 views
  • 03 Feb, 2022
  • 1 location
Clinical Trial on Remote Ischemic Conditioning in Acute Ischemic Stroke Within 9 Hours of Onset in Patients Ineligible to Recanalization Therapies

Phase II, prospective, randomized, multicenter, open-label, pilot clinical trial comparing remote ischemic conditioning (RIC) plus standard medical therapy to standard medical therapy alone, in patients with acute ischemic stroke within 9 hours of stroke onset that are not eligible to recanalization therapies.

  • 10 views
  • 29 Aug, 2021
  • 3 locations
Ticagrelor Versus Clopidogrel in Carotid Artery Stenting (PRECISE-MRI)

Patients with symptomatic or asymptomatic carotid stenosis in whom carotid artery stenting is planned are randomised between antiplatelet therapy with ticagrelor plus aspirin or clopidogrel plus

transient ischemic attack
MRI
stenosis
aspirin
atherosclerosis
  • 97 views
  • 16 Mar, 2022
  • 14 locations
TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome.

patients undergoing PCI compared to clopidogrel. This benefit came without any increase in major bleedings compared to clopidogrel (6). In the PLATO trial, a limited number of kidney failure

  • 0 views
  • 30 Jan, 2021
  • 1 location
Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion

This study is a prospective, open label, two-arm, randomized multicenter trial to evaluate the efficacy and safety of aspirin plus prasugrel as compared with aspirin plus clopidogrel in patients

in stent restenosis
antiplatelet therapy
clopidogrel
percutaneous coronary intervention
prasugrel
  • 0 views
  • 19 Nov, 2021
  • 1 location